CVS Group plc (LON:CVSG - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 954.70 ($12.31) and traded as high as GBX 999 ($12.88). CVS Group shares last traded at GBX 951 ($12.26), with a volume of 5,040,254 shares.
CVS Group Price Performance
The stock has a market capitalization of £681.61 million, a P/E ratio of 32.92, a PEG ratio of 1.77 and a beta of 1.02. The business has a fifty day simple moving average of GBX 1,017.16 and a 200-day simple moving average of GBX 951.83. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09.
CVS Group (LON:CVSG - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported GBX 40 ($0.52) earnings per share (EPS) for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. Sell-side analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, insider Richard Gray sold 305 shares of the firm's stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of GBX 1,007 ($12.98), for a total transaction of £3,071.35 ($3,958.95). 5.83% of the stock is currently owned by insiders.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Further Reading
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
